Drug Shortage Report for PMS-CYTARABINE

Last updated on 2020-06-10 History
Report ID 4178
Drug Identification Number 02406772
Brand name PMS-CYTARABINE
Common or Proper name CYTARABINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Packaging size 20ml
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-23
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments
Health Canada comments
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-06-10 French Compare
v13 2020-06-10 English Compare
v12 2017-08-11 French Compare
v11 2017-08-11 English Compare
v10 2017-07-11 French Compare
v9 2017-07-11 English Compare
v8 2017-06-16 French Compare
v7 2017-06-16 English Compare
v6 2017-06-09 French Compare
v5 2017-06-09 English Compare
v4 2017-05-12 French Compare
v3 2017-05-12 English Compare
v2 2017-03-24 French Compare
v1 2017-03-24 English Compare